Crystal structures of the neurotrophin-binding domain of TrkA, TrkB and TrkC - PubMed (original) (raw)
. 1999 Jul 2;290(1):149-59.
doi: 10.1006/jmbi.1999.2816.
Affiliations
- PMID: 10388563
- DOI: 10.1006/jmbi.1999.2816
Crystal structures of the neurotrophin-binding domain of TrkA, TrkB and TrkC
M H Ultsch et al. J Mol Biol. 1999.
Abstract
The Trk receptors and their neurotrophin ligands control development and maintenance of the nervous system. The crystal structures of the ligand binding domain of TrkA, TrkB, and TrkC were solved and refined to high resolution. The domains adopt an immunoglobulin-like fold, but crystallized in all three instances as dimers with the N-terminal strand of each molecule replaced by the same strand of a symmetry-related mate. Models of the correctly folded domains could be constructed by changing the position of a single residue, and the resulting model of the binding domain of TrkA is essentially identical with the bound structure as observed in a complex with nerve growth factor. An analysis of the existing mutagenesis data for TrkA and TrkC in light of these structures reveals the structural reasons for the specificity among the Trk receptors, and explains the underpinnings of the multi-functional ligands that have been reported. The overall structure of all three domains belongs to the I-set of immunoglobulin-like domains, but shows several unusual features, such as an exposed disulfide bridge linking two neighboring strands in the same beta-sheet. For all three domains, the residues that deviate from the standard fingerprint pattern common to the I-set family fall in the region of the ligand binding site observed in the complex. Therefore, identification of these deviations in the sequences of other immunoglobulin-like domain-containing receptors may help to identify their ligand binding site even in the absence of structural or mutagenesis data.
Copyright 1998 Academic Press.
Similar articles
- Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor.
Wiesmann C, Ultsch MH, Bass SH, de Vos AM. Wiesmann C, et al. Nature. 1999 Sep 9;401(6749):184-8. doi: 10.1038/43705. Nature. 1999. PMID: 10490030 - Immunoglobulin-like domains define the nerve growth factor binding site of the TrkA receptor.
Holden PH, Asopa V, Robertson AG, Clarke AR, Tyler S, Bennett GS, Brain SD, Wilcock GK, Allen SJ, Smith SK, Dawbarn D. Holden PH, et al. Nat Biotechnol. 1997 Jul;15(7):668-72. doi: 10.1038/nbt0797-668. Nat Biotechnol. 1997. PMID: 9219271 - [Neurotrophins. I: Molecular features].
Zazpe A, Del Río J. Zazpe A, et al. Rev Med Univ Navarra. 1997 Jul-Sep;41(3):173-9. Rev Med Univ Navarra. 1997. PMID: 10420923 Review. Spanish. - Structural and functional properties of the TRK family of neurotrophin receptors.
Barbacid M. Barbacid M. Ann N Y Acad Sci. 1995 Sep 7;766:442-58. doi: 10.1111/j.1749-6632.1995.tb26693.x. Ann N Y Acad Sci. 1995. PMID: 7486690 Review.
Cited by
- Modification of a Selective NTRK2 Agonist and Confirmation of Activity in a Glaucoma-on-a-Chip Model.
Nafian F, Yazdani S, Javad Rasaee M, Kamali Doust Azad B, Daftarian N, Rezaei Kanavi M. Nafian F, et al. J Ophthalmic Vis Res. 2024 Mar 14;19(1):58-70. doi: 10.18502/jovr.v19i1.15439. eCollection 2024 Jan-Mar. J Ophthalmic Vis Res. 2024. PMID: 38638624 Free PMC article. - Selective type II TRK inhibitors overcome xDFG mutation mediated acquired resistance to the second-generation inhibitors selitrectinib and repotrectinib.
Xiang S, Lu X. Xiang S, et al. Acta Pharm Sin B. 2024 Feb;14(2):517-532. doi: 10.1016/j.apsb.2023.11.010. Epub 2023 Nov 8. Acta Pharm Sin B. 2024. PMID: 38322338 Free PMC article. Review. - Nerve Growth Factor and Autoimmune Diseases.
Terracina S, Ferraguti G, Tarani L, Fanfarillo F, Tirassa P, Ralli M, Iannella G, Polimeni A, Lucarelli M, Greco A, Fiore M. Terracina S, et al. Curr Issues Mol Biol. 2023 Nov 10;45(11):8950-8973. doi: 10.3390/cimb45110562. Curr Issues Mol Biol. 2023. PMID: 37998739 Free PMC article. Review. - Legumain Functions as a Transient TrkB Sheddase.
Holzner C, Böttinger K, Blöchl C, Huber CG, Dahms SO, Dall E, Brandstetter H. Holzner C, et al. Int J Mol Sci. 2023 Mar 11;24(6):5394. doi: 10.3390/ijms24065394. Int J Mol Sci. 2023. PMID: 36982466 Free PMC article. - Pharmacophore-Aided Virtual Screening and Molecular Dynamics Simulation Identifies TrkB Agonists for Treatment of _CDKL5_-Deficiency Disorders.
Ademuwagun IA, Oduselu GO, Rotimi SO, Adebiyi E. Ademuwagun IA, et al. Bioinform Biol Insights. 2023 Mar 2;17:11779322231158254. doi: 10.1177/11779322231158254. eCollection 2023. Bioinform Biol Insights. 2023. PMID: 36895324 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases